Module 3 / Lesson 9.4
Pandemics and the Future
Exploring how biotechnology has evolved into a strategic domain with both transformative potential and catastrophic risks.
Lesson 10.4 explores how modern biotechnology has evolved from a health-oriented discipline into a strategic domain with both transformative potential and catastrophic risks. It connects the technical capabilities of genetic engineering, vaccine platforms, and synthetic biology with the societal, ethical, and security challenges they now pose. This lesson examines the tension between biomedical innovation and biosecurity vulnerability.
This lesson has three sub-lessons:
Key Takeaways
- Biotechnology offers unprecedented medical and humanitarian benefits, but also lowers the threshold for catastrophic misuse.
- The duality of biotech, healing and harming, requires a new global ethic of responsibility and transparency.
- AI integration accelerates both innovation and risk, demanding proactive governance before crises emerge.
- Effective management of bio-risks will define whether biotechnology becomes a pillar of resilience or a vector of existential threat in the 21st century.
Your progress stays in this browser.